Homocysteine and Parkinson's disease
CNS Neuroscience & Therapeutics · 2024-02 · 30 (2)
DOI: 10.1111/cns.14420 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 29.08.2023. Verfasst von Lingyan Zhou. Beteiligte Einrichtung: Department of Neurology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Parkinson Disease, Hyperhomocysteinemia. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Homocysteine (Hcy) is an important metabolite in methionine metabolism. When the metabolic pathway of homocysteine is abnormal, it will accumulate in the body and eventually lead to hyperhomocysteinemia. In recent years, many studies have found that hyperhomocysteinemia is related to the occurrence and development of Parkinson's disease. This study reviews the roles of homocysteine in the pathogenesis of Parkinson's disease and illustrates the harmful effects of hyperhomocysteinemia on Parkinson's disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
ORCID-Profile: Lingyan Zhou
Zitieren
APA
Zhou, L. (2024). Homocysteine and Parkinson's disease. CNS Neuroscience & Therapeutics, 30(2). https://doi.org/10.1111/cns.14420
Vancouver
Zhou L. Homocysteine and Parkinson's disease. CNS Neuroscience & Therapeutics. 2024;30(2). doi:10.1111/cns.14420
BibTeX
@article{Zhou2024,
author = {Zhou, Lingyan},
title = {Homocysteine and Parkinson's disease},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
volume = {30},
number = {2},
doi = {10.1111/cns.14420}
}
EUVIMED